Syndax Pharmaceuticals Inc Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Syndax Pharmaceuticals Inc annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2021.
  • Syndax Pharmaceuticals Inc Operating Lease, Payments for the quarter ending February 28, 2021 was $270K.
  • Syndax Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $924K, a 63% increase from 2022.
  • Syndax Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $567K, a 4.23% increase from 2021.
  • Syndax Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $544K, a 8.88% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2021 $270K Feb 1, 2021 Feb 28, 2021 10-K 2022-03-01
Q1 2019 $140K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.